Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biorientation of chromosomes in cell division 1 pseudogene 2 (BOD1P2) is annotated as a pseudogene in the human genome. Pseudogenes are gene sequences that resemble known genes but have lost their protein-coding ability or functionality due to mutations. There is no evidence that BOD1P2 encodes a functional protein, nor is it known to play an active role in cellular biology, disease pathogenesis, or drug interactions. It is not considered a therapeutic target and lacks experimental evidence for protein product, biological function, or disease involvement.
None (No known mechanism as a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biorientation of chromosomes in cell division 1 pseudogene 2 (BOD1P2).